ISL
Ingalls & Snyder LLC Portfolio holdings
AUM
$2.81B
This Quarter Return
-21.99%
1 Year Return
+59.04%
3 Year Return
+136.26%
5 Year Return
+243.92%
10 Year Return
+513.42%
AUM
$1.47B
AUM Growth
+$1.47B
(-20%)
Cap. Flow
+$169M
Cap. Flow
% of AUM
11.47%
Top 10 Holdings %
Top 10 Hldgs %
31.92%
Holding
442
New
56
Increased
57
Reduced
212
Closed
48
Top Buys
| 1 |
Apple
AAPL
|
$53.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$48.3M |
| 3 |
Abbott
ABT
|
$16.1M |
| 4 |
Bank of America
BAC
|
$15M |
| 5 |
Globe Life
GL
|
$12M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
$3.52M |
| 2 |
Oracle
ORCL
|
$3.15M |
| 3 |
Cimpress
CMPR
|
$2.33M |
| 4 |
Simon Property Group
SPG
|
$2.25M |
| 5 |
Copart
CPRT
|
$2.15M |
Sector Composition
| 1 | Healthcare | 22.74% |
| 2 | Technology | 14.17% |
| 3 | Financials | 14% |
| 4 | Energy | 9.78% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
International Paper
IP
$25.4B
| $1.37M | 0.09% |
44,129
-5,000
| -10% | -$156K |
|
152
Methanex
MEOH
$2.73B
| $1.37M | 0.09% |
112,275
-70,440
| -39% | -$857K |
|
|
CEMI
153
DELISTED
Chembio diagnostics, Inc.
CEMI
| $1.36M | 0.09% |
266,473
-42,771
| -14% | -$219K |
|
154
Novo Nordisk
NVO
$252B
| $1.34M | 0.09% |
22,318
| – | – |
|
155
LiqTech
LIQT
$20.3M
| $1.34M | 0.09% |
311,595
-2,250
| -0.7% | -$9.68K |
|
156
McDonald's
MCD
$226B
| $1.31M | 0.09% |
7,937
-557
| -7% | -$92.1K |
|
157
3M
MMM
$81B
| $1.31M | 0.09% |
9,589
-370
| -4% | -$50.6K |
|
158
abrdn Physical Platinum Shares ETF
PPLT
$1.64B
| $1.31M | 0.09% |
+19,260
| New | +$1.31M |
|
|
SRG
159
Seritage Growth Properties
SRG
$205M
| $1.3M | 0.09% |
142,812
-14,126
| -9% | -$129K |
|
160
Nu Skin
NUS
$596M
| $1.3M | 0.09% |
59,386
+6,009
| +11% | +$131K |
|
161
Philip Morris
PM
$254B
| $1.3M | 0.09% |
17,770
-169
| -0.9% | -$12.3K |
|
162
Air Lease Corp
AL
$7.13B
| $1.29M | 0.09% |
58,364
-9,739
| -14% | -$216K |
|
163
ConocoPhillips
COP
$118B
| $1.29M | 0.09% |
41,822
-4,860
| -10% | -$150K |
|
164
Meta Platforms (Facebook)
META
$1.85T
| $1.28M | 0.09% |
7,647
-120
| -2% | -$20K |
|
165
Supernus Pharmaceuticals
SUPN
$2.52B
| $1.27M | 0.09% |
70,688
| – | – |
|
|
RDS.B
166
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.25M | 0.08% |
38,158
-45,853
| -55% | -$1.5M |
|
167
Diageo
DEO
$61.1B
| $1.24M | 0.08% |
9,766
-144
| -1% | -$18.3K |
|
|
AGN
168
DELISTED
Allergan plc
AGN
| $1.24M | 0.08% |
7,003
-56
| -0.8% | -$9.92K |
|
|
MNR
169
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $1.24M | 0.08% |
102,781
-2,826
| -3% | -$34.1K |
|
170
BP
BP
$88.8B
| $1.22M | 0.08% |
+50,026
| New | +$1.22M |
|
171
Texas Instruments
TXN
$178B
| $1.21M | 0.08% |
12,086
-172
| -1% | -$17.2K |
|
172
AstraZeneca
AZN
$255B
| $1.19M | 0.08% |
+26,719
| New | +$1.19M |
|
173
McKesson
MCK
$85.9B
| $1.18M | 0.08% |
8,737
+5,385
| +161% | +$729K |
|
174
Verisk Analytics
VRSK
$37.5B
| $1.18M | 0.08% |
8,470
-650
| -7% | -$90.6K |
|
175
Cognizant
CTSH
$35.1B
| $1.15M | 0.08% |
24,776
-14,431
| -37% | -$670K |
|